Skip to main content

BRIEF-Biocept's CEO issues letter to stockholders

* Biocept- Later in year, plan to initiate commercial pilot program for hospital-based pathologists to interpret results of co's liquid biopsy tests locally Source text for Eikon: Further company coverage:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.